The global “Hemostats Market Size” is anticipated to USD 5.44 billion by the end of 2025. The growth of this region is accountable for the increasing incidences of sports-related injuries worldwide. A hemostat is a surgical tool used for controlling the flow of blood at the time of performing operations. According to a recent report by Fortune Business Insights titled, “Hemostats Market Size, Share & Industry Analysis, By Product Type (Active Hemostats, Passive Hemostats, Combination Hemostats, Others), By Application (Trauma, Cardiovascular Surgery, General Surgery, Plastic Surgery, Orthopedic Surgery, Neurosurgery, Others), By End, User (Hospitals, Ambulatory Surgical Centers, Tactical Combat Casualty Care Centers, Others) and Regional Forecast, 2018-2025,” the value of this market was USD 3.33 billion in 2017 and is expected to exhibit a CAGR of 6.4% between 2018 and 2025.
The report covers:
- Global Hemostats Market trends, with detailed analysis on consumer trends & manufacturer trends.
- Overview on supply analysis covering trends across raw material suppliers, technology providers and distributors.
- Key areas of investments identifying market opportunities and challenges in forecast timeframe.
- Competitive analysis of the industry players along with the overview on strategic management.
- Comprehensive company profiles of the major industry players.
Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/hemostatic-agents-market-100084
Leading Players operating in the Hemostats Market are:
Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:
- Baxter International Inc.
- Pfizer Inc.
- CryoLife Inc.
- Ethicon LLC
- Integra Life Sciences
- Other players
The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this, too, shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. Some industries are struggling, and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.
We are making continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.
For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/hemostatic-agents-market-100084
Passive Hemostats Segment to Hold Dominance Owing to Improved Patient Outcomes
Based on segmentation by product, the passive hemostats segment earned a 48.1% share in 2017 and gained dominance owing to various advantages offered by this segment. This includes minimal complications, improved patient outcomes, and cost-efficiency.
North America to Dominate Market on Account of Presence of Increasing Number of Ambulatory Patients Opting Surgery
Geographically, North America earned a revenue of USD 1.17 billion in 2017 and emerged dominant, attributable to the rise in the number of surgeries and supported interventions for controlling blood loss during operations from the government. This, coupled with the high rate of hospital visits including both inpatient and ambulatory patients opting for therapeutic and invasive surgeries are likely to help this region continue dominating the market in the forthcoming years.
On the other side, the Asia Pacific hemostats market share is likely to rise at a rapid pace in the coming years on account of increasing disposable incomes of people in the country and their willingness to spend more on better healthcare and medical facilities and the adoption of advanced technology in the healthcare sector of the region.
Detailed Table of Content:
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
- Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
4.1. Key strategies of leading market players
4.2. Technological advancements
4.3. Key mergers and acquisitions
4.4. Key performance indicators
- Middle East and Africa Hemostats Market Analysis, Insights and Forecast,2014-2025
10.1. Key Findings/ Summary
10.2. Market Analysis – By Application
10.2.2. Cardiovascular Surgery
10.2.3. General Surgery
10.2.4. Plastic Surgery
10.2.5. Orthopedic Surgery
10.3. Market Analysis – By Product
10.3.1. Active Hemostats
10.3.1.1. Thrombin based Hemostats
10.3.1.2. Fibrin Sealants
10.3.2. Passive Hemostats
10.3.2.1. Plant-based Hemostats
10.3.2.2. Animal-based Hemostats
10.3.3. Combination Hemostats
10.4. Market Analysis– By End User
10.4.2. Ambulatory Surgical Centers
10.4.3. Tactical Combat Casualty Care Centers
10.5. Market Analysis – By Country
10.5.2. South Africa
10.5.3. Rest of Middle East & Africa
Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/hemostatic-agents-market-100084
- Extensive product offerings
- Customer research services
- Robust research methodology
- Comprehensive reports
- Latest technological developments
- Value chain analysis
- Potential Hemostats Market opportunities
- Growth dynamics
- Quality assurance
- Post-sales support
- Regular report updates
Reasons to Purchase this Report:
- Comprehensive analysis of the Hemostats Market growth drivers, obstacles, opportunities, and other related challenges.
- Tracks the developments, such as new product launches, agreements, mergers and acquisitions, geographical expansions, and joint ventures.
- Identifies market restraints and boosters.
- Identifies all the possible segments present in the market to aid organizations in strategic business planning.
More Trending Topics from Fortune Business Insights:
Orthopedic Devices Market to Rise at 6.6% CAGR and Reach USD 68.51 Billion by by 2027; Increasing Prevalence of Musculoskeletal Disorders will Emerge in Favor of Market Growth, says Fortune Business Insights™
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune – 411045, Maharashtra, India.
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245